Geoffrey Lynn

Company: Barinthus Biotherapeutics

Job title: Senior Vice President Synthetic Immunotherapies

Seminars:

Intramuscularly Administered SNAP-TI Nanoparticles Induce Systemic Antigen-Specific Tolerance 10:00 am

Introducing the SNAP-TI platform and mechanism of action in animal models of Type 1 Diabetes and Multiple Sclerosis Discussing the VTP-1000 drug product candidate based on SNAP-TI for celiac diseaseRead more

day: Conference Day Two